Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
This allows the medication to be absorbed into the bloodstream quickly
When used for weight management, the evidence increasingly supports long-term or indefinite treatment for patients who respond well and tolerate the medication particularly those with obesity-related cardiovascular risk factors
But with patience, experimentation, and a focus on nourishment from the inside out, you can create a solid foundation for health well into your later years
After 24 weeks, mean weight loss with phentermine/topiramate ER in PCOS obese women was 8%, even higher than the 6.6% Weight loss reported at 56 weeks in the general population [171] However, cardiovascular safety concerns persist for this drug, particularly in people with PCOS, who are already at increased risk for cardiovascular complications compared to the general population [172]
Many people on GLP-1 medications experience these problems
Benvenga et al
